Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PCRX
PCRX logo

PCRX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

PCRX News

PharmaCorp to Present at 2026 Healthcare Investor Conference

Apr 02 2026Yahoo Finance

DOMA Calls for Replacement of Pacira Management

Mar 12 2026Newsfilter

DOMA Nominates New Directors to Revitalize Pacira

Mar 11 2026Newsfilter

Pacira BioSciences Q4 2025 Earnings Call Insights

Feb 27 2026seekingalpha

San Francisco Expands Free Childcare Access, Saving Families Thousands Annually

Jan 14 2026seekingalpha

Pacira BioSciences Partners with LG Chem to Expand Access to EXPAREL in Asia-Pacific Markets

Jan 13 2026NASDAQ.COM

Pacira BioSciences to Present at 44th Annual J.P. Morgan Healthcare Conference

Jan 07 2026Globenewswire

PharmaCorp Grants 501,088 Options at $0.46 Exercise Price

Jan 01 2026Yahoo Finance

PCRX Events

03/11 13:10
Doma Nominates Three Director Candidates to Improve Pacira's Financial Management
Doma Perpetual Capital Management, which owns 7.1% of Pacira's outstanding shares, announced its nomination of three director candidates to Pacira's board: Christopher Dennis, Oliver Benton Curtis and Eric de Armas. Doma believes "electing these nominees is critical to address the Board's lack of financial controls, sophistication and legal expertise, and to develop proper management oversight at the Board level." It added, "Doma's aim is to generate profit for the Company's shareholders, who have been forced to weather consistent year-over-year declines in the stock price while Company expenses and Management compensation have soared. Doma believes the Board must avoid taking any further risk with IP battles and has previously privately notified members of the Board of its concern that the Board's actions may potentially constitute gross negligence."

PCRX Monitor News

No data

No data

PCRX Earnings Analysis

No Data

No Data

People Also Watch